Matinas BioPharma Holdings (MTNB) Preferred Shares (2016 - 2021)
Matinas BioPharma Holdings (MTNB) posted quarterly Preferred Shares of $3.7 million for Q1 2021, down 7.34% year-over-year from $4.0 million in Q1 2020, and down 3.28% quarter-over-quarter from $3.8 million in Q4 2020.
Matinas BioPharma Holdings (MTNB) Preferred Shares (2016 - 2021) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Preferred Shares for 6 consecutive years, with $3.7 million the latest figure, recorded in Q1 2021.
- In Q1 2021, Preferred Shares fell 7.34% year-over-year to $3.7 million; the TTM figure through Mar 2021 stood at $3.7 million (down 7.34% YoY), while the FY2020 annual figure was $3.8 million, down 4.72% from the prior year.
- Preferred Shares retreated to $3.7 million in Q1 2021 per MTNB's latest filing, from $3.8 million in the prior quarter.
- Across five years, Preferred Shares topped out at $6.1 million in Q3 2018 and bottomed at $3.7 million in Q1 2021.
- Historically, Preferred Shares has averaged $4.9 million across 5 years, with a median of $5.6 million in 2018.
- Annual changes were most pronounced in 2018 — Preferred Shares increased 6.32% — and 2019, when it sank 34.03%.
- Matinas BioPharma Holdings' Preferred Shares stood at $5.7 million in 2017, then slipped by 2.33% to $5.6 million in 2018, then fell by 28.62% to $4.0 million in 2019, then decreased by 4.72% to $3.8 million in 2020, then fell by 3.28% to $3.7 million in 2021.
- Business Quant data shows MTNB's Preferred Shares at $3.7 million in Q1 2021, $3.8 million in Q4 2020, and $4.0 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.93 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.86 Bn | 53.73 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.42 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.19 Bn | 9.80 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 1.22 Mn | 406,176.27 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 3.67 Mn |
| Dec 31, 2020 | 3.80 Mn |
| Sep 30, 2020 | 3.96 Mn |
| Jun 30, 2020 | 3.96 Mn |
| Mar 31, 2020 | 3.96 Mn |
| Dec 31, 2019 | 3.99 Mn |
| Sep 30, 2019 | 4.02 Mn |
| Jun 30, 2019 | 4.03 Mn |
| Mar 31, 2019 | 5.58 Mn |
| Dec 31, 2018 | 5.58 Mn |
| Sep 30, 2018 | 6.10 Mn |
| Jun 30, 2018 | 5.58 Mn |
| Mar 31, 2018 | 5.60 Mn |
| Dec 31, 2017 | 5.72 Mn |
| Sep 30, 2017 | 5.74 Mn |
| Jun 30, 2017 | 5.80 Mn |
| Mar 31, 2017 | 6.05 Mn |
| Dec 31, 2016 | 6.09 Mn |
| Sep 30, 2016 | 6.09 Mn |